The Gastrointestinal Safety of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials
The bottom line: Food and beverage suppliers and retailers and restaurant and foodservice operators are likely to see Americans volume of purchases and caloric consumption meaningfully decrease as the burgeoning market for GLP-1 drugs draws more users, PwC said
Further studies demonstrated its effectiveness alone and in combination with other clinical drugs or natural compounds in several diseases, including cancers
Amylin analogues such as cagrilintide and eloralintide target the amylin receptor to enhance satiety and slow gastric emptying
*Correspondence: Jun Xu, [email protected] This article was submitted to Endocrinology of Aging, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Product Highlights: Convenient liquid formula for fast absorption
